![Rosanne Robinson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermogen: 319 037 $ op 31-05-2026
Rosanne Elizabeth Robinson currently works at Clarity Pharmaceuticals Ltd., as Lead Independent Director from 2024, Australian Nuclear Science & Technology Organisation, as General Manager-Business Development, and Cyclotek Pty Ltd., as Chief Financial Officer.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 22-08-2025 | 178.079 ( 0,05% ) | 319 037 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| CLARITY PHARMACEUTICALS LTD | Directeur/Bestuurslid | 01-10-2010 |
Australian Nuclear Science & Technology Organisation | Corporate Officer/Principal | - |
Cyclotek Pty Ltd.
 Cyclotek Pty Ltd. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical and medicine manufacturing | Financieel Directeur/CFO | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
Australian Nuclear Science & Technology Organisation | |
Clarity Pharmaceuticals Ltd.
 Clarity Pharmaceuticals Ltd. Medical SpecialtiesHealth Technology Develops radiopharmaceutical products | Health Technology |
Cyclotek Pty Ltd.
Cyclotek Pty Ltd. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical and medicine manufacturing | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau
